000 | 01351 a2200409 4500 | ||
---|---|---|---|
005 | 20250515152719.0 | ||
264 | 0 | _c20090303 | |
008 | 200903s 0 0 eng d | ||
022 | _a1433-6510 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aShastri, Yogesh M | |
245 | 0 | 0 |
_aComparison of a novel fecal marker--fecal tumor pyruvate kinase type M2 (M2-PK) with fecal calprotectin in patients with inflammatory bowel disease: a prospective study. _h[electronic resource] |
260 |
_bClinical laboratory _c2008 |
||
300 |
_a389-90 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aBiomarkers _xanalysis |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 |
_aFeces _xchemistry |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInflammatory Bowel Diseases _xdiagnosis |
650 | 0 | 4 |
_aLeukocyte L1 Antigen Complex _xanalysis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aPyruvate Kinase _xanalysis |
650 | 0 | 4 | _aSensitivity and Specificity |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aPovse, Nada | |
700 | 1 | _aSchröder, Oliver | |
700 | 1 | _aStein, Jürgen | |
773 | 0 |
_tClinical laboratory _gvol. 54 _gno. 9-10 _gp. 389-90 |
|
999 |
_c18548619 _d18548619 |